ESMO Virtual Preceptorship on Hereditary Cancer Genetics 2021
- Start date
- 27 May 2021
- End date
- 27 May 2021
- Location
- Virtual, CEST Time
Learning objectives
- To learn about the best clinical practice in the multidisciplinary management of hereditary cancer syndromes
- To understand the molecular basis and heterogeneity of the genetic susceptibility to develop cancer
- To learn how to recognize, diagnose, treat and provide prevention recommendations to patients with a germline genetic susceptibility
Accreditation
The programme of this virtual event has been accredited with 5 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-chairs
- Judith Balmaña, Spain
- Nicoline Hoogerbrugge, Netherlands